Skin cancer in non-white liver transplant recipients: Mayo Clinic experience

Leila M. Tolaymat, Danielle K. Reimer, Joshua Feig, Melinda S. Gillis, Leigh L. Speicher, Claire B. Haga, Emmanuel M. Gabriel, Michael G. Heckman, Mingyuan Yin, Scott W. Fosko, Andrew P. Keaveny, Nancy L. Dawson

Research output: Contribution to journalArticlepeer-review


Background: Limited data are available on the development of skin cancer and the associated risk factors for non-White liver transplant (LT) recipients. The aim of this study is to determine the incidence of newly diagnosed skin cancer postoperatively and to identify the risk factors for the development of skin cancer in non-White LT recipients. Methods: We conducted an initial retrospective chart review of non-White LT patients who received a transplant at our center between January 1, 2011, and December 31, 2013. Results: Of the 96 patients in the study cohort, 32% were Black, 17% were Asian, 15% were White Hispanic, and 10% were Black Hispanic. One patient had a history of nonmelanoma skin cancer before transplant. No skin cancers were diagnosed during follow-up (median, 1.3 years; range, 17 days to 8.6 years). Conclusion: Our center’s experience is consistent with the literature and suggests that the incidence of newly diagnosed skin cancer in non-White liver transplant recipients is low. Longer follow-up may provide additional insights into the specific risk factors for the posttransplant development of skin cancer.

Original languageEnglish (US)
Pages (from-to)986-990
Number of pages5
JournalInternational journal of dermatology
Issue number8
StatePublished - Aug 2021

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'Skin cancer in non-white liver transplant recipients: Mayo Clinic experience'. Together they form a unique fingerprint.

Cite this